Stockholders` Deficit

12 Months Ended

Dec. 31, 2023

Stockholders` Deficit [Line Items]

Equity [Text Block]

14.  Stockholders’ Deficit

During 2023 and 2022, the Board of Directors did not declare any quarterly cash dividends on the Company’s Common Stock.

The Company was authorized to issue 2,500,000 shares of preferred stock as of December 31, 2023, of which (i) 416,500 shares were designated as Series A Convertible Preferred Stock, none of which were outstanding, (ii) 51,000 shares were designated as Series B Convertible Preferred Stock (“SBCPS”), none of which were outstanding, and (iii) 2,032,500 shares were not yet designated.  The undesignated preferred stock would contain such rights, preferences, privileges and restrictions as may be fixed by our Board of Directors.

Shares of the Company’s Common Stock reserved for future issuance in connection with convertible securities and stock option plans were 1.8 million and 1.9 million at December 31, 2023 and 2022, respectively.

Accumulated other comprehensive loss is comprised of approximately $6.1 million and $6.2 million of unrecognized pension costs at December 31, 2023 and 2022, respectively, and $153,000 and $98,000 of unrealized foreign currency translation gains at December 31, 2023 and 2022, respectively.

The components of accumulated other comprehensive loss are as follows:

In thousands	Pension plan actuarial (loss) gain		Foreign currency translation gain (loss)		Total
Balances at January 1, 2022	$	(6,516)	$	263	$	(6,253)
Actuarial gain		352		-		352
Translation loss		-		(165)		(165)
Balances at December 31, 2022		(6,164)		98		(6,066)
Actuarial gain		63		-		63
Translation gain		-		54		54
Balances at December 31, 2023	$	(6,101)	$	152	$	(5,949)